{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:44:37Z","timestamp":1788371077206,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.pbb.2011.10.012","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T10:33:12Z","timestamp":1319452392000},"page":"490-493","source":"Crossref","is-referenced-by-count":21,"title":["Quetiapine improves response inhibition in alcohol dependent patients: A placebo-controlled pilot study"],"prefix":"10.1016","volume":"100","author":[{"given":"Nathasha","family":"Moallem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara A.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2011.10.012_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000321345","article-title":"Laboratory paradigms of impulsivity and alcohol dependence: a review","volume":"17","author":"Aragues","year":"2011","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.pbb.2011.10.012_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nn1003","article-title":"Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans","volume":"6","author":"Aron","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2011.10.012_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00213-009-1537-0","article-title":"Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats","volume":"205","author":"Bari","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.10.012_bb0020","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4088\/JCP.v67n0705","article-title":"Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: a pilot study","volume":"67","author":"Bellino","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2011.10.012_bb0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/npp.2009.162","article-title":"Dissociable control of impulsivity in rats by dopamine d2\/3 receptors in the core and shell subregions of the nucleus accumbens","volume":"35","author":"Besson","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.10.012_bb0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4088\/JCP.v69n0502","article-title":"A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders","volume":"69","author":"Brown","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2011.10.012_bb0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00213-005-0104-6","article-title":"Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity","volume":"182","author":"Clark","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.10.012_bb0040","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/npp.2008.202","article-title":"Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition","volume":"34","author":"Eagle","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.10.012_bb0045","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1523\/JNEUROSCI.6182-10.2011","article-title":"Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats","volume":"31","author":"Eagle","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.10.012_bb0135","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders \u2014 Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"1995"},{"key":"10.1016\/j.pbb.2011.10.012_bb0055","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1530-0277.2010.01243.x","article-title":"Effects of alcohol cue exposure on response inhibition in detoxified alcohol-dependent patients","volume":"34","author":"Gauggel","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2011.10.012_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.addbeh.2010.11.006","article-title":"A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients","volume":"36","author":"Guardia","year":"2011","journal-title":"Addict Behav"},{"key":"10.1016\/j.pbb.2011.10.012_bb0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/15622970309167910","article-title":"Quetiapine in the treatment of borderline personality disorder","volume":"4","author":"Hilger","year":"2003","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.10.012_bb0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2011.10.012_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/PL00005483","article-title":"Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli","volume":"146","author":"Jentsch","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.10.012_bb0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/JCP.0b013e3180ca86e5","article-title":"A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism","volume":"27","author":"Kampman","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.10.012_bb0085","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2011.10.012_bb0090","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1530-0277.2008.00891.x","article-title":"Altered impulse control in alcohol dependence: neural measures of stop signal performance","volume":"33","author":"Li","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2011.10.012_bb0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.jcp.0000138763.23482.2a","article-title":"Quetiapine for treatment of alcohol dependence","volume":"24","author":"Monnelly","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.10.012_bb0100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pnpbp.2006.08.012","article-title":"Quetiapine for the treatment of borderline personality disorder; an open-label study","volume":"31","author":"Perrella","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.10.012_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.npp.1301073","article-title":"Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task","volume":"32","author":"Pezze","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.10.012_bb0110","doi-asserted-by":"crossref","unstructured":"Ray LA, Chin PF, Heydari A, Miotto K. A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology 2011;317(3):341\u201351.","DOI":"10.1007\/s00213-011-2287-3"},{"key":"10.1016\/j.pbb.2011.10.012_bb0115","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1530-0277.2008.00746.x","article-title":"The role of behavioral impulsivity in the development of alcohol dependence: a 4-year follow-up study","volume":"32","author":"Rubio","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2011.10.012_bb0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/JCP.0b013e3181bfdb79","article-title":"Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence","volume":"29","author":"Rubio","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.10.012_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JCP.0b013e318166c4bf","article-title":"Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder","volume":"28","author":"Van den Eynde","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.10.012_bb0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hup.1075","article-title":"Quetiapine treatment and improved cognitive functioning in borderline personality disorder","volume":"24","author":"Van den Eynde","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.10.012_bb1000","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4088\/JCP.v66n1013","article-title":"Open-label study of atypical neuroleptic, quetiapine for treatment of borderline personality disorder: impulsivity as main target","volume":"66","author":"Villeneuve","year":"2005","journal-title":"J Clin Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711003418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711003418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T02:24:16Z","timestamp":1543458256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711003418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0091305711003418"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.10.012","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}